(Updates with closing share price in second paragraph.)
Nov. 29 (Bloomberg) -- Evogene Ltd. rose the most in more than two months after the developer of plant traits for the agriculture and biofuel industries extended and expanded a collaboration agreement with Monsanto Co.
The shares increased 5.5 percent, the biggest gain since Sept. 26, to 14.96 shekels at the 4:30 p.m. close in Tel Aviv.
--Editors: Shanthy Nambiar, Peter Branton
To contact the reporter on this story: Shoshanna Solomon in Tel Aviv at email@example.com
To contact the editor responsible for this story: Claudia Maedler at firstname.lastname@example.org